The DOI matches its Crossref record.
The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality
Open accessAbstract
Patients receiving allopurinol are at risk of developing the allopurinol hypersensitivity syndrome, an immunologic reaction to the drug, characterized by multiple abnormalities such as fever, rash, decreased renal function, hepatocellular injury, leukocytosis, and eosinophilia. The records of 8 patients with the allopurinol hypersensitivity syndrome evaluated at the Downstate Medical Center hospitals and an additional 72 patients described in the literature were reviewed. All were seriously ill. Three of the 8 patients at the Down‐state Medical Center hospitals died as a result of allopurinol hypersensitivity; 19 of the 72 previously described patients also died from consequences of taking the drug. Only 1 of our 8 patients with allopurinol hypersensitivity was given allopurinol for an appropriate reason. Eight of the 59 previously described patients on whom there was adequate information had legitimate indications for allopurinol therapy. Severe, often fatal iatrogenic disease occurred unnecessarily in the others.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
Becker, M. A., Schumacher, H. R., Wortmann, R. L., MacDonald, P. A., Eustace, D., Palo, W. A., Streit, J., & Joseph-Ridge, N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050373 · Cited by 1,357
Asymptomatic hyperuricemia. Risks and consequences in the normative aging study
Campion, E. W., Glynn, R. J., & Delabry, L. O. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90441-4 · Cited by 851
Schumacher, H. R., Becker, M. A., Wortmann, R. L., MacDonald, P. A., Hunt, B., Streit, J., Lademacher, C., & Joseph‐Ridge, N. (2008) · Arthritis Care & Research · doi:10.1002/art.24209 · Cited by 638
Halevy, S., Ghislain, P.-D., Mockenhaupt, M., Fagot, J.-P., Bouwes Bavinck, J. N., Sidoroff, A., Naldi, L., Dunant, A., Viboud, C., & Roujeau, J.-C. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.08.036 · Cited by 479
Drug Reaction With Eosinophilia and Systemic Symptoms: A Retrospective Study of 60 Cases
Chen, Y.-C., Chiu, H.-C., & Chu, C.-Y. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.198 · Cited by 350
Suzuki, Y., Inagi, R., Aono, T., Yamanishi, K., & Shiohara, T. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.9.1108 · Cited by 349
Tohyama, M., Hashimoto, K., Yasukawa, M., Kimura, H., Horikawa, T., Nakajima, K., Urano, Y., Matsumoto, K., Iijima, M., & Shear, N. H. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08167.x · Cited by 341
Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase
Takano, Y., Hase-Aoki, K., Horiuchi, H., Zhao, L., Kasahara, Y., Kondo, S., & Becker, M. A. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.10.031 · Cited by 334
Allopurinol Hypersensitivity Syndrome: A Review
Arellano, F., & Sacristán, J. A. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700317 · Cited by 318
Wortmann, R. L. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200205000-00015 · Cited by 304
Becker, M. A., Schumacher, H. R., Wortmann, R. L., MacDonald, P. A., Palo, W. A., Eustace, D., Vernillet, L., & Joseph‐Ridge, N. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20935 · Cited by 266
Perez-Ruiz, F., Alonso-Ruiz, A., Calabozo, M., Herrero-Beites, A., García-Erauskin, G., & Ruiz-Lucea, E. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.9.545 · Cited by 257
Metadata
- Authors
- Singer, J. Z., & Wallace, S. L.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1986-01
- Volume
- 29
- Issue
- 1
- Pages
- 82-87
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2154564423
- Cited by
- 245
- References
- 0
- FWCI
- 7.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.